Vistra Corp. (VST) Outperforms Broader Market: What You Need to Know — Positive

VST   Zacks Investment Research — February 10, 2025

In the closing of the recent trading day, Vistra Corp. (VST) stood at $168.39, denoting a +0.89% change from the preceding trading day.

image for news Vistra Corp. (VST) Outperforms Broader Market: What You Need to Know

Why Sea Limited Sponsored ADR (SE) Outpaced the Stock Market Today — Positive

SE   Zacks Investment Research — February 10, 2025

Sea Limited Sponsored ADR (SE) concluded the recent trading session at $125.28, signifying a +1.85% move from its prior day's close.

image for news Why Sea Limited Sponsored ADR (SE) Outpaced the Stock Market Today

Cava Group (CAVA) Exceeds Market Returns: Some Facts to Consider — Neutral

CAVA   Zacks Investment Research — February 10, 2025

In the closing of the recent trading day, Cava Group (CAVA) stood at $140.62, denoting a +1.6% change from the preceding trading day.

image for news Cava Group (CAVA) Exceeds Market Returns: Some Facts to Consider

Target (TGT) Stock Dips While Market Gains: Key Facts — Neutral

TGT   Zacks Investment Research — February 10, 2025

Target (TGT) closed the most recent trading day at $131.28, moving -0.05% from the previous trading session.

image for news Target (TGT) Stock Dips While Market Gains: Key Facts

Costco (COST) Surpasses Market Returns: Some Facts Worth Knowing — Positive

COST   Zacks Investment Research — February 10, 2025

Costco (COST) concluded the recent trading session at $1,061.92, signifying a +1.73% move from its prior day's close.

image for news Costco (COST) Surpasses Market Returns: Some Facts Worth Knowing

Lululemon (LULU) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Negative

LULU   Zacks Investment Research — February 10, 2025

Lululemon (LULU) concluded the recent trading session at $399.71, signifying a +0.4% move from its prior day's close.

image for news Lululemon (LULU) Rises Yet Lags Behind Market: Some Facts Worth Knowing

TJX (TJX) Rises But Trails Market: What Investors Should Know — Neutral

TJX   Zacks Investment Research — February 10, 2025

In the most recent trading session, TJX (TJX) closed at $124.97, indicating a +0.22% shift from the previous trading day.

image for news TJX (TJX) Rises But Trails Market: What Investors Should Know

Novavax (NVAX) Outperforms Broader Market: What You Need to Know — Positive

NVAX   Zacks Investment Research — February 10, 2025

In the closing of the recent trading day, Novavax (NVAX) stood at $8.19, denoting a +0.74% change from the preceding trading day.

image for news Novavax (NVAX) Outperforms Broader Market: What You Need to Know

Here's Why Veeva Systems (VEEV) Gained But Lagged the Market Today — Positive

VEEV   Zacks Investment Research — February 10, 2025

In the latest trading session, Veeva Systems (VEEV) closed at $237.81, marking a +0.26% move from the previous day.

image for news Here's Why Veeva Systems (VEEV) Gained But Lagged the Market Today

Why Li Auto Inc. Sponsored ADR (LI) Outpaced the Stock Market Today — Positive

LI   Zacks Investment Research — February 10, 2025

The latest trading day saw Li Auto Inc. Sponsored ADR (LI) settling at $26.37, representing a +1.35% change from its previous close.

image for news Why Li Auto Inc. Sponsored ADR (LI) Outpaced the Stock Market Today

Toll Brothers (TOL) Beats Stock Market Upswing: What Investors Need to Know — Positive

TOL   Zacks Investment Research — February 10, 2025

In the closing of the recent trading day, Toll Brothers (TOL) stood at $125.21, denoting a +0.69% change from the preceding trading day.

image for news Toll Brothers (TOL) Beats Stock Market Upswing: What Investors Need to Know

Walmart (WMT) Surpasses Market Returns: Some Facts Worth Knowing — Positive

WMT   Zacks Investment Research — February 10, 2025

Walmart (WMT) concluded the recent trading session at $102.92, signifying a +1.75% move from its prior day's close.

image for news Walmart (WMT) Surpasses Market Returns: Some Facts Worth Knowing

Inspire Medical's Earnings Surge in Q4 — Positive

INSP   The Motley Fool — February 10, 2025

Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.

image for news Inspire Medical's Earnings Surge in Q4

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=128514&wire=1 or contact Joseph E. Levi, Esq.

image for news TELUS International (Cda) Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - TIXT

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news APLT FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

SAN DIEGO, CA / ACCESS Newswire / February 10, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSE:GSK) between February 5, 2020 and August 14, 2022. GSK is a global pharmaceutical company that develops, manufactures, and markets vaccines and medicines worldwide.

image for news GSK Class Action News: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Involving GSK PLC

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=128513&wire=1 or contact Joseph E. Levi, Esq.

image for news MU LAWSUIT ALERT: Levi & Korsinsky Notifies Micron Technology, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of TELUS International (Cda) Inc. (NYSE: TIXT) between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

image for news TIXT Investors Have Opportunity to Lead TELUS International (Cda) Inc. Securities Fraud Lawsuit

RCI Hospitality (RICK) Q1 Earnings and Revenues Beat Estimates — Positive

RICK   Zacks Investment Research — February 10, 2025

RCI Hospitality (RICK) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.77 per share a year ago.

image for news RCI Hospitality (RICK) Q1 Earnings and Revenues Beat Estimates

Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates — Positive

MEDP   Zacks Investment Research — February 10, 2025

Medpace (MEDP) came out with quarterly earnings of $3.67 per share, beating the Zacks Consensus Estimate of $2.97 per share. This compares to earnings of $2.46 per share a year ago.

image for news Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates